cloudfront

Report Detail



Pharma & HealthcareGlobal Rosuvastatin Market Insights, Forecast to 2025

  • RnM2419430
  • |
  • 14 September, 2018
  • |
  • Global
  • |
  • 126 pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

Global Rosuvastatin Market Insights, Forecast to 2025

Table of Contents

    1 Study Coverage

    • 1.1 Rosuvastatin Product
    • 1.2 Key Market Segments
    • 1.3 Key Manufacturers Covered
    • 1.4 Market by Type
      • 1.4.1 Global Rosuvastatin Market Size Growth Rate by Type
      • 1.4.2 Purity 98.0%
      • 1.4.3 Purity 99.0%
      • 1.4.4 Other
    • 1.5 Market by Application
      • 1.5.1 Global Rosuvastatin Market Size Growth Rate by Application
      • 1.5.2 Tablet
      • 1.5.3 Capsule
      • 1.5.4 Others
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Executive Summary

    • 2.1 Global Rosuvastatin Market Size
      • 2.1.1 Global Rosuvastatin Revenue 2016-2025
      • 2.1.2 Global Rosuvastatin Sales 2016-2025
    • 2.2 Rosuvastatin Growth Rate by Regions
      • 2.2.1 Global Rosuvastatin Sales by Regions
      • 2.2.2 Global Rosuvastatin Revenue by Regions

    3 Breakdown Data by Manufacturers

    • 3.1 Rosuvastatin Sales by Manufacturers
      • 3.1.1 Rosuvastatin Sales by Manufacturers
      • 3.1.2 Rosuvastatin Sales Market Share by Manufacturers
      • 3.1.3 Global Rosuvastatin Market Concentration Ratio (CR5 and HHI)
    • 3.2 Rosuvastatin Revenue by Manufacturers
      • 3.2.1 Rosuvastatin Revenue by Manufacturers (2016-2018)
      • 3.2.2 Rosuvastatin Revenue Share by Manufacturers (2016-2018)
    • 3.3 Rosuvastatin Price by Manufacturers
    • 3.4 Rosuvastatin Manufacturing Base Distribution, Product Types
      • 3.4.1 Rosuvastatin Manufacturers Manufacturing Base Distribution, Headquarters
      • 3.4.2 Manufacturers Rosuvastatin Product Category
      • 3.4.3 Date of International Manufacturers Enter into Rosuvastatin Market
    • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type

    • 4.1 Global Rosuvastatin Sales by Type
    • 4.2 Global Rosuvastatin Revenue by Type
    • 4.3 Rosuvastatin Price by Type

    5 Breakdown Data by Application

    • 5.1 Overview
    • 5.2 Global Rosuvastatin Breakdown Data by Application

    6 North America

    • 6.1 North America Rosuvastatin by Countries
      • 6.1.1 North America Rosuvastatin Sales by Countries
      • 6.1.2 North America Rosuvastatin Revenue by Countries
      • 6.1.3 United States
      • 6.1.4 Canada
      • 6.1.5 Mexico
    • 6.2 North America Rosuvastatin by Type
    • 6.3 North America Rosuvastatin by Application
    • 6.4 North America Rosuvastatin by Company

    7 Europe

    • 7.1 Europe Rosuvastatin by Countries
      • 7.1.1 Europe Rosuvastatin Sales by Countries
      • 7.1.2 Europe Rosuvastatin Revenue by Countries
      • 7.1.3 Germany
      • 7.1.4 France
      • 7.1.5 UK
      • 7.1.6 Italy
      • 7.1.7 Russia
    • 7.2 Europe Rosuvastatin by Type
    • 7.3 Europe Rosuvastatin by Application
    • 7.4 Europe Rosuvastatin by Company

    8 Asia Pacific

    • 8.1 Asia Pacific Rosuvastatin by Countries
      • 8.1.1 Asia Pacific Rosuvastatin Sales by Countries
      • 8.1.2 Asia Pacific Rosuvastatin Revenue by Countries
      • 8.1.3 China
      • 8.1.4 Japan
      • 8.1.5 Korea
      • 8.1.6 India
      • 8.1.7 Australia
      • 8.1.8 Indonesia
      • 8.1.9 Malaysia
      • 8.1.10 Philippines
      • 8.1.11 Thailand
      • 8.1.12 Vietnam
      • 8.1.13 Singapore
    • 8.2 Asia Pacific Rosuvastatin by Type
    • 8.3 Asia Pacific Rosuvastatin by Application
    • 8.4 Asia Pacific Rosuvastatin by Company

    9 Central & South America

    • 9.1 Central & South America Rosuvastatin by Countries
      • 9.1.1 Central & South America Rosuvastatin Sales by Countries
      • 9.1.2 Central & South America Rosuvastatin Revenue by Countries
      • 9.1.3 Brazil
    • 9.2 Central & South America Rosuvastatin by Type
    • 9.3 Central & South America Rosuvastatin by Application
    • 9.4 Central & South America Rosuvastatin by Company

    10 Middle East and Africa

    • 10.1 Middle East and Africa Rosuvastatin by Countries
      • 10.1.1 Middle East and Africa Rosuvastatin Sales by Countries
      • 10.1.2 Middle East and Africa Rosuvastatin Revenue by Countries
      • 10.1.3 GCC Countries
      • 10.1.4 Turkey
      • 10.1.5 Egypt
      • 10.1.6 South Africa
    • 10.2 Middle East and Africa Rosuvastatin by Type
    • 10.3 Middle East and Africa Rosuvastatin by Application
    • 10.4 Middle East and Africa Rosuvastatin by Company

    11 Company Profiles

    • 11.1 AstraZeneca
      • 11.1.1 AstraZeneca Company Details
      • 11.1.2 Company Description
      • 11.1.3 Sales, Revenue and Gross Margin of Rosuvastatin
      • 11.1.4 Rosuvastatin Product Description
      • 11.1.5 Recent Development
    • 11.2 Teva Pharmaceutical Industries
      • 11.2.1 Teva Pharmaceutical Industries Company Details
      • 11.2.2 Company Description
      • 11.2.3 Sales, Revenue and Gross Margin of Rosuvastatin
      • 11.2.4 Rosuvastatin Product Description
      • 11.2.5 Recent Development
    • 11.3 MSN Laboratories
      • 11.3.1 MSN Laboratories Company Details
      • 11.3.2 Company Description
      • 11.3.3 Sales, Revenue and Gross Margin of Rosuvastatin
      • 11.3.4 Rosuvastatin Product Description
      • 11.3.5 Recent Development
    • 11.4 Cadila Pharmaceuticals
      • 11.4.1 Cadila Pharmaceuticals Company Details
      • 11.4.2 Company Description
      • 11.4.3 Sales, Revenue and Gross Margin of Rosuvastatin
      • 11.4.4 Rosuvastatin Product Description
      • 11.4.5 Recent Development
    • 11.5 LGM Pharma
      • 11.5.1 LGM Pharma Company Details
      • 11.5.2 Company Description
      • 11.5.3 Sales, Revenue and Gross Margin of Rosuvastatin
      • 11.5.4 Rosuvastatin Product Description
      • 11.5.5 Recent Development
    • 11.6 Bal Pharma
      • 11.6.1 Bal Pharma Company Details
      • 11.6.2 Company Description
      • 11.6.3 Sales, Revenue and Gross Margin of Rosuvastatin
      • 11.6.4 Rosuvastatin Product Description
      • 11.6.5 Recent Development
    • 11.7 Changzhou Pharmaceutical Factory
      • 11.7.1 Changzhou Pharmaceutical Factory Company Details
      • 11.7.2 Company Description
      • 11.7.3 Sales, Revenue and Gross Margin of Rosuvastatin
      • 11.7.4 Rosuvastatin Product Description
      • 11.7.5 Recent Development
    • 11.8 Jingxin Pharm
      • 11.8.1 Jingxin Pharm Company Details
      • 11.8.2 Company Description
      • 11.8.3 Sales, Revenue and Gross Margin of Rosuvastatin
      • 11.8.4 Rosuvastatin Product Description
      • 11.8.5 Recent Development
    • 11.9 Zhejiang Hisun Pharmaceutical
      • 11.9.1 Zhejiang Hisun Pharmaceutical Company Details
      • 11.9.2 Company Description
      • 11.9.3 Sales, Revenue and Gross Margin of Rosuvastatin
      • 11.9.4 Rosuvastatin Product Description
      • 11.9.5 Recent Development
    • 11.10 HEC Pharm
      • 11.10.1 HEC Pharm Company Details
      • 11.10.2 Company Description
      • 11.10.3 Sales, Revenue and Gross Margin of Rosuvastatin
      • 11.10.4 Rosuvastatin Product Description
      • 11.10.5 Recent Development
    • 11.11 Lunan Pharmaceutical
    • 11.12 Nanjing Frochem Tech
    • 11.13 Lianyungang Runzhong Pharmaceutical
    • 11.14 Shandong Bechem Chemicals
    • 11.15 CTX Life Sciences

    12 Market Opportunities, Challenges, Risks and Influences Factors Analysis

    • 12.1 Market Opportunities and Drivers
    • 12.2 Market Challenges
    • 12.3 Market Risks/Restraints
    • 12.4 Key World Economic Indicators

    13 Value Chain and Sales Channels Analysis

    • 13.1 Value Chain Analysis
      • 13.1.1 Typical Suppliers of Key Rosuvastatin Raw Material
      • 13.1.2 Rosuvastatin Customers
    • 13.2 Sales Channels Analysis
      • 13.2.1 Sales Channels Analysis
      • 13.2.2 Distributors

    14 Research Findings and Conclusion

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 15.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Author Details

      This report studies the global market size of Rosuvastatin in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Rosuvastatin in these regions.
      This research report categorizes the global Rosuvastatin market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter's Five Forces Analysis.

      In 2017, the global Rosuvastatin market size was million US$ and is forecast to million US in 2025, growing at a CAGR of from 2018. The objectives of this study are to define, segment, and project the size of the Rosuvastatin market based on company, product type, application and key regions.

      The various contributors involved in the value chain of Rosuvastatin include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in the Rosuvastatin include
      AstraZeneca
      Teva Pharmaceutical Industries
      MSN Laboratories
      Cadila Pharmaceuticals
      LGM Pharma
      Bal Pharma
      Changzhou Pharmaceutical Factory
      Jingxin Pharm
      Zhejiang Hisun Pharmaceutical
      HEC Pharm
      Lunan Pharmaceutical
      Nanjing Frochem Tech
      Lianyungang Runzhong Pharmaceutical
      Shandong Bechem Chemicals
      CTX Life Sciences

      Market Size Split by Type
      Purity 98.0%
      Purity 99.0%
      Other
      Market Size Split by Application
      Tablet
      Capsule
      Others

      Market size split by Region
      North America
      United States
      Canada
      Mexico
      Asia-Pacific
      China
      India
      Japan
      South Korea
      Australia
      Indonesia
      Singapore
      Malaysia
      Philippines
      Thailand
      Vietnam
      Europe
      Germany
      France
      UK
      Italy
      Spain
      Russia
      Central & South America
      Brazil
      Rest of Central & South America
      Middle East & Africa
      GCC Countries
      Turkey
      Egypt
      South Africa

      The study objectives of this report are:
      To study and analyze the global Rosuvastatin market size (value & volume) by company, key regions/countries, products and application, history data from 2013 to 2017, and forecast to 2025.
      To understand the structure of Rosuvastatin market by identifying its various subsegments.
      To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
      Focuses on the key global Rosuvastatin manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
      To analyze the Rosuvastatin with respect to individual growth trends, future prospects, and their contribution to the total market.
      To project the value and volume of Rosuvastatin submarkets, with respect to key regions (along with their respective key countries).
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
      To strategically profile the key players and comprehensively analyze their growth strategies.

      In this study, the years considered to estimate the market size of Rosuvastatin are as follows:
      History Year: 2013-2017
      Base Year: 2017
      Estimated Year: 2018
      Forecast Year 2018 to 2025

      This report includes the estimation of market size for value (million US$) and volume (K MT). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Rosuvastatin market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

      For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.




      Summary:
      Get latest Market Research Reports on Rosuvastatin . Industry analysis & Market Report on Rosuvastatin is a syndicated market report, published as Global Rosuvastatin Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Rosuvastatin market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.


      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,900.00
      $7,800.00
      2,618.85
      5,237.70
      3,588.78
      7,177.56
      472,446.00
      944,892.00
      258,622.26
      517,244.52
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report